Omschrijving
This book focuses on the safety efforts being implemented in paediatric drug development. Although children suffer from many of the same diseases as adults and are often treated with the same drugs, only about one-third of the drugs that are prescribed for children have been studied and labelled for paediatric use. This has placed children taking drugs for which there have not been adequate paediatric drug studies at risk of being exposed to ineffective treatment or receiving incorrect dosing. In order to encourage the study of more drugs for paediatric use, Congress passed the Best Pharmaceuticals for Children Act (BPCA) in 2002 to provide marketing incentives to drug manufacturers for conducting paediatric drug studies. Drug manufacturers may obtain six months of additional market exclus
Kenmerken
| Artikelnummer | 1001004007156175 |
|---|---|
| EAN | 9781607415657 |
| Categorie | Educational Books |
| Productgroep | Boeken |
| Segment | Textual/Printed/Reference Materials |
| Prijs Nederland | € 119,26 |
| Prijs België | € 119,26 |
| Verzendkosten NL | Gratis |
| Verzendkosten BE | Gratis |
| Levertijd Nederland | Over 13 dagen |
| Levertijd België | Over 13 dagen |
| Verkoper | Partner |
Safety Efforts in Pediatric Drug Development bestellen bij snelkeus
Koop Safety Efforts in Pediatric Drug Development van Onbekend online in de categorie Educational Books. Prijs € 119,26, levering in Nederland · Over 13 dagen.